Journal of Thrombosis and Thrombolysis

Papers
(The H4-Index of Journal of Thrombosis and Thrombolysis is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Characteristics and comparisons of acute stroke in “recovered" to “active COVID-19 and “pre-pandemic” in Qatar database52
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team45
Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection38
Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia31
Management of bone marrow biopsy related bleeding risks: a retrospective observational study29
Association of the careggi collateral score with radiological outcomes after thrombectomy for stroke with an occlusion of the middle cerebral artery29
Towards a personalized selection of antithrombotic agents in patients undergoing PCI: the role of clinical presentation in tools for risk assessment28
Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors25
Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians24
Direct oral anticoagulants for secondary stroke prevention in patients over 80 years of age: the role of geriatric functional status23
Variables associated with adequate INR reversal in warfarin treated patients receiving 4-factor prothrombin complex concentrate22
Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry22
Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic21
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone20
Patterns of vascular access device use and thrombosis outcomes in patients with COVID-19: a pilot multi-site study of Michigan hospitals18
Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy18
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series18
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison17
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes17
0.11517596244812